Altogether, these data indicated that hMSC transplantation both augments angiogenesis and blunts fibrosis and inflammation after ischemia, while knockout of HIF-1α abrogates the angiogenic and therapeutic potential of hMSCs. Here, HIF1A is linked to ischemia.